Structural investigation of methyl 3-(4-fluoro-benzo-yl)-7-methyl-2-phenyl-indolizine-1-carboxyl-ate, an inhibitory drug towards Mycobacterium tuberculosis .

MLA

Hasija, Avantika, et al. “Structural Investigation of Methyl 3-(4-Fluoro-Benzo-Yl)-7-Methyl-2-Phenyl-Indolizine-1-Carboxyl-Ate, an Inhibitory Drug towards Mycobacterium Tuberculosis .” Acta Crystallographica. Section E, Crystallographic Communications, vol. 76, no. Pt 4, Mar. 2020, pp. 567–71. EBSCOhost, https://doi.org/10.1107/S2056989020003837.

APA

Hasija, A., Bhandary, S., Venugopala, K. N., Chandrashekharappa, S., & Chopra, D. (2020). Structural investigation of methyl 3-(4-fluoro-benzo-yl)-7-methyl-2-phenyl-indolizine-1-carboxyl-ate, an inhibitory drug towards Mycobacterium tuberculosis . Acta Crystallographica. Section E, Crystallographic Communications, 76(Pt 4), 567–571. https://doi.org/10.1107/S2056989020003837

Chicago

Hasija, Avantika, Subhrajyoti Bhandary, Katharigatta N Venugopala, Sandeep Chandrashekharappa, and Deepak Chopra. 2020. “Structural Investigation of Methyl 3-(4-Fluoro-Benzo-Yl)-7-Methyl-2-Phenyl-Indolizine-1-Carboxyl-Ate, an Inhibitory Drug towards Mycobacterium Tuberculosis .” Acta Crystallographica. Section E, Crystallographic Communications 76 (Pt 4): 567–71. doi:10.1107/S2056989020003837.